1. Volume 70, Pages S21-S25 (December 2006)
The economic realities of erythropoiesis-stimulating agent therapy in kidney disease 
J.B. Wish 
Kidney International 
Volume 70, Pages S21-S25 (December 2006)
DOI: /sj.ki
Copyright © 2006 International Society of Nephrology Terms and Conditions

2. Figure 1
EPO use in HD: 1989–1993.1
Kidney International  , S21-S25DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

3. Figure 2
Treatment of CKD patients with epoetin varies across the United States (2001–2002).9
Kidney International  , S21-S25DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions

4. Figure 3 Prevalance of ESA Therapy by Stage of CKD.
Kidney International  , S21-S25DOI: ( /sj.ki )
Copyright © 2006 International Society of Nephrology Terms and Conditions